Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network | Zendy

Eva Hoster | Zendy; Wolfram Klapper | Zendy; Olivier Hermine | Zendy; Hanneke C. KluinNelemans | Zendy; Jan Walewski | Zendy; Achiel Van Hoof | Zendy; Marek Trněný | Zendy; Christian H. Geisler | Zendy; Francesco Di Raimondo | Zendy; Michał Szymczyk | Zendy; Stephan Stilgenbauer | Zendy; Catherine Thiéblemont | Zendy; Michael Hallek | Zendy; Roswitha Forstpointner | Zendy; Christiane Pott | Zendy; Vincent Ribrag | Zendy; Jeanette K. Doorduijn | Zendy; Wolfgang Hiddemann | Zendy; Martin Dreyling | Zendy; Michael Unterhalt | Zendy

Open Access

Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network

Author(s) -

Eva Hoster,

Wolfram Klapper,

Olivier Hermine,

Hanneke C. KluinNelemans,

Jan Walewski,

Achiel Van Hoof,

Marek Trněný,

Christian H. Geisler,

Francesco Di Raimondo,

Michał Szymczyk,

Stephan Stilgenbauer,

Catherine Thiéblemont,

Michael Hallek,

Roswitha Forstpointner,

Christiane Pott,

Vincent Ribrag,

Jeanette K. Doorduijn,

Wolfgang Hiddemann,

Martin Dreyling,

Michael Unterhalt

Publication year - 2014

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2013.52.2466

Subject(s) - mantle cell lymphoma , medicine , international prognostic index , hazard ratio , cohort , clinical trial , oncology , lymphoma , diffuse large b cell lymphoma , confidence interval

Mantle-cell lymphoma (MCL) is a distinct B-cell lymphoma associated with poor outcome. In 2008, the MCL International Prognostic Index (MIPI) was developed as the first prognostic stratification tool specifically directed to patients with MCL. External validation was planned to be performed on the cohort of the two recently completed randomized trials of the European MCL Network.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research